Texas Cardiac Arrhythmia Research Foundation
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Texas Cardiac Arrhythmia Research Foundation sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
Texas Cardiac Arrhythmia Research Foundation: 15 sponsored US clinical trials, none currently recruiting.
Texas Cardiac Arrhythmia Research Foundation sponsors 15 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 14 completed. 9 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atrial Fibrillation, with 3 trials.
Top-decile sponsor footprint
Texas Cardiac Arrhythmia Research Foundation ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
14 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
15 total, page 1 of 1
Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Centers (SAFFICIENT)
NCT06488820
Half-normal Saline in Atrial Fibrillation Ablation
NCT03498586
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT02208102
Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation
NCT02533843
Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)
NCT01751607
Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation
NCT01660100
Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter
NCT01439386
Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine
NCT01391091
Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
NCT01362738
Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation
NCT01173809
The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
NCT01148914
Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes
NCT01173796
Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
NCT01045668
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
NCT01006876
Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
NCT00729911
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 8 |
| Phase 4 | 1 |
Therapeutic Areas
How the Texas Cardiac Arrhythmia Research Foundation archive is shaped
15 indexed studies, none listed as recruiting (0% open); 14 completed (93%).
Phase mix: 9 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Atrial Fibrillation (3 trials), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Texas Cardiac Arrhythmia Research Foundation: archived-pipeline peers nationwide
Peers matched on 15 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Texas Cardiac Arrhythmia Research Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 archived trials
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Texas Cardiac Arrhythmia Research Foundation page
15 registered trials is a research-attention snapshot, not an endorsement of Texas Cardiac Arrhythmia Research Foundation or any single study.
- None of Texas Cardiac Arrhythmia Research Foundation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Atrial Fibrillation is the condition Texas Cardiac Arrhythmia Research Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Fibrillation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Texas Cardiac Arrhythmia Research Foundation pipeline card: 15 registered trials from official public datasets.Report a data error.